Sökning: WFRF:(Derendorf Hartmut) > (2010-2014) > Protein Binding :
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02531naa a2200349 4500 | |
001 | oai:DiVA.org:uu-156025 | |
003 | SwePub | |
008 | 110706s2011 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1560252 URI |
024 | 7 | a https://doi.org/10.1128/AAC.01433-102 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Zeitlinger, Markus A.4 aut |
245 | 1 0 | a Protein Binding :b Do We Ever Learn? |
264 | 1 | c 2011 |
338 | a print2 rdacarrier | |
520 | a Although the influence of protein binding (PB) on antibacterial activity has been reported for many antibiotics and over many years, there is currently no standardization for pharmacodynamic models that account for the impact of protein binding of antimicrobial agents in vitro. This might explain the somewhat contradictory results obtained from different studies. Simple in vitro models which compare the MIC obtained in protein-free standard medium versus a protein-rich medium are prone to methodological pitfalls and may lead to flawed conclusions. Within in vitro test systems, a range of test conditions, including source of protein, concentration of the tested antibiotic, temperature, pH, electrolytes, and supplements may influence the impact of protein binding. As new antibiotics with a high degree of protein binding are in clinical development, attention and action directed toward the optimization and standardization of testing the impact of protein binding on the activity of antibiotics in vitro become even more urgent. In addition, the quantitative relationship between the effects of protein binding in vitro and in vivo needs to be established, since the physiological conditions differ. General recommendations for testing the impact of protein binding in vitro are suggested. | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Derendorf, Hartmut4 aut |
700 | 1 | a Mouton, Johan W.4 aut |
700 | 1 | a Cars, Ottou Uppsala universitet,Infektionssjukdomar4 aut0 (Swepub:uu)ottocars |
700 | 1 | a Craig, William A.4 aut |
700 | 1 | a Andes, David4 aut |
700 | 1 | a Theuretzbacher, Ursula4 aut |
710 | 2 | a Uppsala universitetb Infektionssjukdomar4 org |
773 | 0 | t Antimicrobial Agents and Chemotherapyg 55:7, s. 3067-3074q 55:7<3067-3074x 0066-4804x 1098-6596 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-156025 |
856 | 4 8 | u https://doi.org/10.1128/AAC.01433-10 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy